blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2879706

EP2879706 - NOVEL ANTI-PLASMODIUM PARASITE ANTIBODIES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.07.2018
Database last updated on 17.09.2024
FormerThe patent has been granted
Status updated on  04.08.2017
FormerGrant of patent is intended
Status updated on  08.03.2017
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
FRAUNHOFER-GESELLSCHAFT zur Förderung der angewandten Forschung e.V.
Hansastraße 27c
80636 München / DE
[2017/36]
Former [2015/24]For all designated states
FRAUNHOFER-GESELLSCHAFT zur Förderung der angewandten Forschung e.V.
Hansastraße 27c
80636 Munich / DE
Inventor(s)01 / FENDEL, Rolf
Fraunhofer IME
Forckenbeckstr.6
52072 Aachen / DE
02 / KLOCKENBRING, Torsten
Fraunhofer IME
Forckenbeckstr.6
52072 Aachen / DE
03 / BARTH, Stefan
Fraunhofer IME
Forckenbeckstr.6
52072 Aachen / DE
04 / KAPELSKI, Stephanie
Fraunhofer IME
Forckenbeckstr.6
52074 Aachen / DE
05 / MASKUS, Dominika
Fraunhofer IME
Forckenbeckstr.6
52072 Aachen / DE
06 / FISCHER, Rainer
Fraunhofer IME
Forckenbeckstr.6
52074 Aachen / DE
07 / REIMANN, Andreas
Fraunhofer IME
Forckenbeckstr.6
52072 Aachen / DE
 [2015/24]
Representative(s)Roth, Andy Stefan
Dr. Roth Patentanwaltskanzlei
Kaistrasse 5
40221 Düsseldorf / DE
[N/P]
Former [2015/24]Roth, Andy Stefan
Dr. Roth Patentanwaltskanzlei
Columbusstrasse 22
40549 Düsseldorf / DE
Application number, filing date13748000.031.07.2013
[2017/36]
WO2013EP66086
Priority number, dateEP2012017931503.08.2012         Original published format: EP 12179315
US201261679380P03.08.2012         Original published format: US 201261679380 P
[2015/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014020062
Date:06.02.2014
Language:EN
[2014/06]
Type: A1 Application with search report 
No.:EP2879706
Date:10.06.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 06.02.2014 takes the place of the publication of the European patent application.
[2015/24]
Type: B1 Patent specification 
No.:EP2879706
Date:06.09.2017
Language:EN
[2017/36]
Search report(s)International search report - published on:EP06.02.2014
ClassificationIPC:A61K39/00, A61P33/06, C07K16/20
[2017/10]
CPC:
C07K16/205 (EP,US); A61P33/06 (EP); C07K2317/21 (EP,US);
C07K2317/56 (US); C07K2317/565 (US); C07K2317/73 (EP,US);
C07K2317/92 (EP,US); Y02A50/30 (EP,US) (-)
Former IPC [2015/24]A61K39/395, A61P33/06, C07K16/20
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/24]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:NEUARTIGE ANTI-PLASMODIUM-PARASITEN-ANTIKÖRPER[2015/24]
English:NOVEL ANTI-PLASMODIUM PARASITE ANTIBODIES[2015/24]
French:NOUVEAUX ANTICORPS ANTI-PLASMODIUM[2015/24]
Entry into regional phase29.01.2015National basic fee paid 
29.01.2015Designation fee(s) paid 
29.01.2015Examination fee paid 
Examination procedure29.01.2015Examination requested  [2015/24]
02.11.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
02.11.2015Despatch of communication of loss of particular rights: Claims {1}
21.12.2015Amendment by applicant (claims and/or description)
27.06.2016Despatch of a communication from the examining division (Time limit: M04)
22.09.2016Reply to a communication from the examining division
09.03.2017Communication of intention to grant the patent
10.07.2017Fee for grant paid
10.07.2017Fee for publishing/printing paid
10.07.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.06.2016
Opposition(s)07.06.2018No opposition filed within time limit [2018/33]
Request for further processing for:23.12.2015Request for further processing filed
21.12.2015Full payment received (date of receipt of payment)
Request granted
29.01.2016Decision despatched
Fees paidRenewal fee
30.07.2015Renewal fee patent year 03
28.07.2016Renewal fee patent year 04
27.07.2017Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU31.07.2013
AL06.09.2017
AT06.09.2017
CY06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
IT06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
MK06.09.2017
PL06.09.2017
PT06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
TR06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
[2020/34]
Former [2020/31]HU31.07.2013
AT06.09.2017
CY06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
IT06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
MK06.09.2017
PL06.09.2017
PT06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
TR06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2020/28]HU31.07.2013
AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
IT06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
PL06.09.2017
PT06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
TR06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2020/16]AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
IT06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
PL06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
TR06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2019/15]AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
IT06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
PL06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/40]AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
IT06.09.2017
LT06.09.2017
LV06.09.2017
PL06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/35]AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
IT06.09.2017
LT06.09.2017
LV06.09.2017
PL06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SK06.09.2017
SM06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/24]AT06.09.2017
CZ06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
IT06.09.2017
LT06.09.2017
LV06.09.2017
PL06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SK06.09.2017
SM06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/21]CZ06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
RS06.09.2017
SE06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
Former [2018/12]ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
RS06.09.2017
SE06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
Former [2018/11]ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
RS06.09.2017
SE06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
Former [2018/09]FI06.09.2017
LT06.09.2017
SE06.09.2017
NO06.12.2017
Former [2018/08]FI06.09.2017
LT06.09.2017
NO06.12.2017
Former [2018/07]LT06.09.2017
NO06.12.2017
Cited inInternational search[I]  - CASILDA G. BLACK ET AL, "Apical location of a novel EGF-like domain-containing protein of Plasmodium falciparum", MOLECULAR AND BIOCHEMICAL PARASITOLOGY, (20030301), vol. 127, no. 1, doi:10.1016/S0166-6851(02)00308-0, ISSN 0166-6851, pages 59 - 68, XP055045852 [I] 1-58 * page 67, column l, paragraph 2; figures 1-6 *

DOI:   http://dx.doi.org/10.1016/S0166-6851(02)00308-0
 [I]  - PUENTES A ET AL, "Identifying Plasmodium falciparum merozoite surface protein-10 human erythrocyte specific binding regions", BIOCHIMIE, MASSON, PARIS, FR, vol. 87, no. 5, ISSN 0300-9084, (20050501), pages 461 - 472, (20050501), XP027603274 [I] 1-58 * figures 1-6; tables 1,2 *
 [A]  - GIRALDO M A ET AL, "Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection", VACCINE, ELSEVIER LTD, GB, vol. 28, no. 1, doi:10.1016/J.VACCINE.2009.09.046, ISSN 0264-410X, (20091210), pages 7 - 13, (20090925), XP026789439 [A] 1-58 * figures 1-4 *

DOI:   http://dx.doi.org/10.1016/j.vaccine.2009.09.046
by applicantWO9413804
 US4816397
    - NOEDL, H.; SOCHEAT, D.; SATIMAI, W., "Artemisinin-resistant malaria in Asia", THE NEW ENGLAND JOURNAL OF MEDICINE, (2009), vol. 361, pages 540 - 1
    - BORRMANN, S. ET AL., "Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast", PLOS ONE, (2011), vol. 6, page E26005
    - KABAT, E. A.; WU, T. T.; GOTTESMAN, K. S.; FOELLER, C., Sequences of Proteins of Immunological Interest., DIANE PUBLISHING, (1992), vol. 2719
    - CHOTHIA, C.; LESK, A. M., "Canonical structures for the hypervariable regions of immunoglobulins", JOURNAL OF MOLECULAR BIOLOGY, (1987), vol. 196, pages 901 - 17
    - CHOTHIA, C. ET AL., "Conformations of immunoglobulin hypervariable regions", NATURE, vol. 342, pages 877 - 83
    - "By-passing immunization: building high affinity human antibodies by chain shuffling", MARKS, J. D. ET AL., Bioltechnology, NATURE PUBLISHING COMPANY, (1992), vol. 10, pages 779 - 83
    - WARD, E. S.; GÜSSOW, D.; GRIFFITHS, A. D.; JONES, P. T.; WINTER, G., "Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli", NATURE, (1989), vol. 341, pages 544 - 6
    - BIRD, R. E. ET AL., "Single-chain antigen-binding proteins", SCIENCE (NEW YORK, N.Y., (1988), vol. 242, pages 423 - 6
    - HUSTON, J. S. ET AL., "Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1988), vol. 85, pages 5879 - 83
    - HOLLIGER, P.; PROSPERO, T.; WINTER, G., "Diabodies'': small bivalent and bispecific antibody fragments", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1993), vol. 90, pages 6444 - 8
    - REITER, Y.; BRINKMANN, U.; LEE, B.; PASTAN, I., "Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments", NATURE BIOTECHNOLOGY, (1996), vol. 14, pages 1239 - 45
    - HU, S. ET AL., "Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts", CANCER RESEARCH, (1996), vol. 56, pages 3055 - 61
    - POLJAK, R., "J. Production and structure of diabodies", STRUCTURE (LONDON, ENGLAND : 1993, (1994), vol. 2, pages 1121 - 3
    - KIPRIYANOV, S. M.; BREITLING, F.; LITTLE, M.; DÜBEL, S., "Single-chain antibody streptavidin fusions: tetrameric bifunctional scFv-complexes with biotin binding activity and enhanced affinity to antigen", HUMAN ANTIBODIES AND HYBRIDOMAS, (1995), vol. 6, pages 93 - 101
    - KIPRIYANOV, S. M.; DUBEL, S.; BREITLING, F.; KONTERMANN, R. E.; LITTLE, M., "Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies", MOLECULAR IMMUNOLOGY, (1994), vol. 31, pages 1047 - 58
    - TAYLOR, L. D. ET AL., "A transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins", NUCLEIC ACIDS RESEARCH, (1992), vol. 20, pages 6287 - 95
    - GEYSEN, H. M.; MELOEN, R. H.; BARTELING, S. J., "Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1984), vol. 81, pages 3998 - 4002
    - LIVINGSTONE, C. D.; BARTON, G. J., "Protein sequence alignments: a strategy for the hierarchical analysis of residue conservation", COMPUTER APPLICATIONS IN THE BIOSCIENCES: CABIOS, (1993), vol. 9, pages 745 - 56
    - TAYLOR, W. R., "The classification of amino acid conservation", JOURNAL OF THEORETICAL BIOLOGY, (1986), vol. 119, pages 205 - 18
    - DAYHOFF, M. O., Atlas of Protein Sequence and Structure, NATL BIOMEDICAL RESEARCH, (1979), vol. 5, pages 353 - 358
    - SMITH, T. F.; WATERMAN, M. S., "Comparison of biosequences", ADVANCES IN APPLIED MATHEMATICS, (1981), vol. 2, pages 482 - 489
    - ALTSCHUL, S. F.; GISH, W.; MILLER, W.; MYERS, E. W.; LIPMAN, D. J., "Basic local alignment search tool", JOURNAL OF MOLECULAR BIOLOGY, (1990), vol. 215, pages 403 - 10
    - HOOGENBOOM, H. R.; WINTER, G., "By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro", JOURNAL OF MOLECULAR BIOLOGY, (1992), vol. 227, pages 381 - 8
    - REISFELD, R. A. ET AL., Monoclonal antibodies and cancer therapy: proceedings of the Roche-UCLA Symposium held in Park City, Utah, A.R. LISS, (19850126), vol. 609
    - "Production of antigen- specific human monoclonal antibodies from in vitro-primed human splenocytes", BOERNER, P.; LAFOND, R.; LU, W. Z.; BRAMS, P.; ROYSTON, I., Journal of immunology, BALTIMORE, MD. : 1950, (1991), vol. 147, pages 86 - 95
    - ST6CKER, M. ET AL., "Secretion of functional anti-CD30-angiogenin immunotoxins into the supernatant of transfected 293T-cells", PROTEIN EXPRESSION AND PURIFICATION, (2003), vol. 28, pages 211 - 9
    - BOES, A. ET AL., "Affinity purification of a framework 1 engineered mouse/human chimeric IgA2 antibody from tobacco", BIOTECHNOLOGY AND BIOENGINEERING, (2011), vol. 108, pages 2804 - 14
    - SAMBROOK, J.; FRITSCH, E. F.; MANIATIS, T., Molecular Cloning: A Laboratory Manual, 2nd edition., vol. 1-3
    - SAMBROOK J E; F FRITSCH; T MANIATIS, Molecular Cloning A Laboratory Manual, COLD SPRING HARBOR LABORATORY PRESS COLD SPRING HARBOR NEW YORK USA LLLUS PAPER, (1989), vol. 1, 2, 3
    - AUSUBEL, F. M. ET AL., Current protocols in molecular biology, JOHN WILEY & SONS, INC., (1988), vol. 1, 2
    - MOLECULAR REPRODUCTION AND DEVELOPMENT, (1989), vol. 1, pages 146 - 146
    - MCCAFFERTY, J.; GRIFFITHS, A. D.; WINTER, G.; CHISWELL, D. J., "Phage antibodies: filamentous phage displaying antibody variable domains", NATURE, (1990), vol. 348, pages 552 - 4
    - URLAUB, G.; CHASIN, L. A., "Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1980), vol. 77, pages 4216 - 20
    - KAUFMAN, R. J.; SHARP, P. A., "Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary dna gene", JOURNAL OF MOLECULAR BIOLOGY, (1982), vol. 159, pages 601 - 21
    - FRAUSSEN, J. ET AL., "A novel method for making human monoclonal antibodies", JOURNAL OF AUTOIMMUNITY, (2010), vol. 35, pages 130 - 4
    - TILLER, T. ET AL., "Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning", JOURNAL OF IMMUNOLOGICAL METHODS, (2008), vol. 329, pages 112 - 24
    - BROCHET, X.; LEFRANC, M.-P.; GIUDICELLI, V., "MGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis", NUCLEIC ACIDS RESEARCH, (2008), vol. 36, pages W503 - 8
    - ROSENBERG, Y. ET AL., "Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems", PLOS ONE, (2013), vol. 8, page E58724
    - ROESTENBERG, M. ET AL., "Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02", PLOS ONE, (2008), vol. 3, page E3960
    - KUSI, K. A. ET AL., "Immunization with different PfAMA1 alleles in sequence induces clonal imprint humoral responses that are similar to responses induced by the same alleles as a vaccine cocktail in rabbits", MALARIA JOURNAL, (2011), vol. 10, page 40
    - BLACK, C. G.; WANG, L.; WU, T.; COPPEL, R. L., "Apical location of a novel EGF-like domain-containing protein of Plasmodium falciparum", MOLECULAR AND BIOCHEMICAL PARASITOLOGY, (2003), vol. 127, pages 59 - 68
    - MAKLER, M. T. ET AL., "Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity", THE AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (1993), vol. 48, pages 739 - 41
 WO1992US09965
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.